Novartis AG
Patents, Design & Utilities
Last updated:
List of all Novartis AG patents 1,223 in total
Status | Patent |
---|---|
Application | Utility: COMBINATION OF PI3K INHIBITOR AND C-MET INHIBITOR Filling date: 23 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: AZA-QUINOLINE COMPOUNDS AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: Pharmaceutical Combinations Filling date: 23 Sep 2025 Issue date: 8 Sep 2022 |
Grant | Utility: Solid forms comprising an oxime ether compound and a coformer, compositions and methods of use thereof Filling date: 23 Sep 2025 Issue date: 6 Sep 2022 |
Grant | Utility: Process and intermediates Filling date: 23 Sep 2025 Issue date: 6 Sep 2022 |
Grant | Utility: Polyomavirus neutralizing antibodies Filling date: 23 Sep 2025 Issue date: 6 Sep 2022 |
Grant | Utility: Methods for treating disease using inhibitors of bone morphogenetic protein 6 (BMP6) Filling date: 23 Sep 2025 Issue date: 6 Sep 2022 |
Grant | Utility: Automated viscous fluid control in vitreoretinal surgery Filling date: 23 Sep 2025 Issue date: 6 Sep 2022 |
Application | Utility: ORGANIC COMPOUNDS Filling date: 23 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: SURFACTANT SYSTEMS FOR CRYSTALLIZATION OF ORGANIC COMPOUNDS Filling date: 23 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 1 Sep 2022 |
Grant | Utility: 1,2,4-oxadiazole derivatives as liver X receptor agonists Filling date: 23 Sep 2025 Issue date: 30 Aug 2022 |
Grant | Utility: Substituted bisphenyl butanoic ester derivatives as NEP inhibitors Filling date: 23 Sep 2025 Issue date: 30 Aug 2022 |
Grant | Utility: Computer processes behind an enhanced version of aqua Filling date: 23 Sep 2025 Issue date: 30 Aug 2022 |
Grant | Utility: Lipoic acid choline ester compositions and methods of use Filling date: 23 Sep 2025 Issue date: 30 Aug 2022 |
Application | Utility: USES OF MYOSTATIN ANTAGONISTS, COMBINATIONS CONTAINING THEM AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: COMBINATION TREATMENT OF LIVER DISEASES USING FXR AGONISTS Filling date: 23 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: NEW CRYSTALLINE FORMS OF N-(3-(2-(2-HYDROXYETHOXY)-6-MORPHOLINOPYRIDIN-4-YL)-4-METHVLPHENYL)-2 (TRIFLUOROMETHYL)ISONICOTINAMIDE AS RAF INHIBITORS FOR THE TREATMENT OF CANCER Filling date: 23 Sep 2025 Issue date: 25 Aug 2022 |
Application | Utility: NLRP MODULATORS Filling date: 23 Sep 2025 Issue date: 25 Aug 2022 |
Grant | Utility: Piperidinyl-methyl-purineamines as NSD2 inhibitors and anti-cancer agents Filling date: 23 Sep 2025 Issue date: 23 Aug 2022 |
Grant | Utility: Lipids and lipid compositions for the delivery of active agents Filling date: 23 Sep 2025 Issue date: 23 Aug 2022 |
Grant | Utility: Intermittent dosing of MDM2 inhibitor Filling date: 23 Sep 2025 Issue date: 23 Aug 2022 |
Application | Utility: MEDICAL CONTAINER WITH NFC ANTENNA Filling date: 23 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: TREATMENT COMPRISING SGLT INHIBITORS Filling date: 23 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: METHODS FOR TREATING MEIBOMIAN GLAND DYSFUNCTION WITH LIVER X RECEPTOR AGONISTS Filling date: 23 Sep 2025 Issue date: 18 Aug 2022 |
Grant | Utility: Systems and methods for intra-ocular lens advancement Filling date: 23 Sep 2025 Issue date: 16 Aug 2022 |
Grant | Utility: Protein kinase C inhibitors for treatment of uveal melanoma Filling date: 23 Sep 2025 Issue date: 16 Aug 2022 |
Grant | Utility: Chemical process for manufacturing monobactam antibiotic and intermediates thereof Filling date: 23 Sep 2025 Issue date: 16 Aug 2022 |
Grant | Utility: Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy Filling date: 23 Sep 2025 Issue date: 16 Aug 2022 |
Application | Utility: METHODS OF TREATING OR AMELIORATING METABOLIC DISORDERS USING GROWTH DIFFERENTIATION FACTOR 15 (GDF-15) Filling date: 23 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: NLRP3 INFLAMMASOME INHIBITORS Filling date: 23 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: METHODS FOR REDUCING THE OXIDATION LEVEL OF CYSTEINE RESIDUES IN A SECRETED RECOMBINANTLY-EXPRESSED PROTEIN DURING CELL CULTURE Filling date: 23 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: COMPOSITIONS AND METHODS FOR SELECTIVE PROTEIN DEGRADATION Filling date: 23 Sep 2025 Issue date: 11 Aug 2022 |
Grant | Utility: Crystalline forms of N-[4-(Chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(- 1H-pyrazol-5-yl)pyridine-3-carboxamide Filling date: 23 Sep 2025 Issue date: 9 Aug 2022 |
Grant | Utility: Combinations of MDM2 inhibitors with inhibitors of ERK for treating cancers Filling date: 23 Sep 2025 Issue date: 9 Aug 2022 |
Grant | Utility: Dosing schedule of a Wnt inhibitor and an anti-PD-1 antibody molecule in combination Filling date: 23 Sep 2025 Issue date: 9 Aug 2022 |
Grant | Utility: Reclosable folding box with a tamper-evident closure, and folding box blank for producing same Filling date: 23 Sep 2025 Issue date: 9 Aug 2022 |
Application | Utility: PHARMACEUTICAL COMBINATION COMPRISING AN ALK INHIBITOR AND A SHP2 INHIBITOR Filling date: 23 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: CELL BAG ROTATOR Filling date: 23 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: RAPAMYCIN DERIVATIVES Filling date: 23 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: SYSTEMS AND METHODS FOR USER VERIFICATION BASED ON ACTIGRAPHY DATA Filling date: 23 Sep 2025 Issue date: 4 Aug 2022 |
Grant | Utility: 1-Pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2 Filling date: 23 Sep 2025 Issue date: 2 Aug 2022 |
Grant | Utility: Inhaler adapted to read information stored in data storage means of a container Filling date: 23 Sep 2025 Issue date: 2 Aug 2022 |
Grant | Design: Container for pharmaceuticals Filling date: 23 Sep 2025 Issue date: 2 Aug 2022 |
Grant | Design: Container for pharmaceuticals Filling date: 23 Sep 2025 Issue date: 2 Aug 2022 |
Application | Utility: Pharmaceutical Composition Filling date: 23 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: INTERMITTENT DOSING OF MDM2 INHIBITOR Filling date: 23 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY Filling date: 23 Sep 2025 Issue date: 21 Jul 2022 |
Grant | Utility: Sustained delivery of angiopoetin-like 3 polypeptides Filling date: 23 Sep 2025 Issue date: 19 Jul 2022 |
Application | Utility: Constitutive Yeast LLP Promotor-Based Expression Systems Filling date: 23 Sep 2025 Issue date: 14 Jul 2022 |
Showing 1 to 50 of 1223 patents.